P
23.13
-0.09 (-0.39%)
| Previous Close | 23.22 |
| Open | 23.23 |
| Volume | 612,679 |
| Avg. Volume (3M) | 845,847 |
| Market Cap | 2,845,025,280 |
| Price / Earnings (TTM) | 165.21 |
| Price / Earnings (Forward) | 38.61 |
| Price / Sales | 1.52 |
| Price / Book | 4.23 |
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2025 |
| Profit Margin | 0.87% |
| Operating Margin (TTM) | 1.09% |
| Diluted EPS (TTM) | 0.120 |
| Quarterly Revenue Growth (YOY) | 15.60% |
| Quarterly Earnings Growth (YOY) | 41.40% |
| Total Debt/Equity (MRQ) | 0.77% |
| Current Ratio (MRQ) | 1.88 |
| Operating Cash Flow (TTM) | 118.36 M |
| Levered Free Cash Flow (TTM) | 110.63 M |
| Return on Assets (TTM) | 1.21% |
| Return on Equity (TTM) | 3.01% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Mixed | |
| Stock | Privia Health Group, Inc. | Mixed | Bullish |
AIStockmoo Score
0.4
| Analyst Consensus | 2.5 |
| Insider Activity | NA |
| Price Volatility | 1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | 0.38 |
|
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 6.71% |
| % Held by Institutions | 100.20% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Rubicon Founders Llc | 30 Sep 2025 | 5,773,522 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 34.00 (Canaccord Genuity, 47.00%) | Buy |
| Median | 31.00 (34.03%) | |
| Low | 23.00 (Barclays, -0.56%) | Hold |
| Average | 30.50 (31.86%) | |
| Total | 7 Buy, 1 Hold | |
| Avg. Price @ Call | 23.59 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BMO Capital | 13 Nov 2025 | 30.00 (29.70%) | Buy | 23.75 |
| JP Morgan | 13 Nov 2025 | 33.00 (42.67%) | Buy | 23.75 |
| Canaccord Genuity | 12 Nov 2025 | 34.00 (47.00%) | Buy | 24.22 |
| Barclays | 10 Nov 2025 | 23.00 (-0.56%) | Hold | 23.41 |
| 09 Oct 2025 | 22.00 (-4.89%) | Hold | 24.20 | |
| Truist Securities | 10 Nov 2025 | 31.00 (34.03%) | Buy | 23.41 |
| Citizens | 07 Nov 2025 | 31.00 (34.03%) | Buy | 23.43 |
| Evercore ISI Group | 07 Nov 2025 | 30.00 (29.70%) | Buy | 23.43 |
| Stephens & Co. | 24 Sep 2025 | 32.00 (38.35%) | Buy | 23.34 |
| 04 Sep 2025 | 32.00 (38.35%) | Buy | 23.12 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 06 Nov 2025 | Announcement | Privia Health Reports Third Quarter 2025 Financial Results |
| 07 Oct 2025 | Announcement | Privia Health to Report Third Quarter 2025 Results on Thursday, November 6 |
| 23 Sep 2025 | Announcement | Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health |
| 23 Sep 2025 | Announcement | Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |